Module 4 Book Prose#
Treatment planning and personalization#
How do patient-specific factors shape recommendations?
🧑‍🌾 SAMWISE — Student note
Pause before you run the notebook. In your own words:
Whose decision does the essential question above affect?
What baseline and result do you predict before seeing the output?
Which observation would change or strengthen your current view?
What will remain uncertain, and what would you check next?
SAMWISE is a reflection guide, not an answer key or grader. Record your own reasoning; the Populi instructions and published rubric remain authoritative.
Professional Scenario#
You are advising a clinical informatics committee evaluating decision support before adding it to a clinician workflow. The immediate task is to decide what evidence would make a recommendation credible, what risks remain unresolved, and what should happen next. The module’s work product is: clinical decision support safety case with escalation, override, and monitoring requirements focused on treatment planning and personalization: Prototype a treatment option explanation..
The available lab data is deliberately limited: synthetic encounter records with symptoms, contraindications, guideline triggers, and alert outcomes. Treat it as a proxy for reasoning and method practice, not as proof that a real deployment is ready. A graduate-level submission must distinguish between what the proxy exercise demonstrates and what would still require institutional data, stakeholder review, and operational testing.
Core Concepts#
Problem framing: define the decision, population, workflow, or system boundary before choosing a method.
Baseline discipline: compare the proposed AI-enabled approach with an existing process, simple rule, or manual review pattern.
Evidence quality: separate measured results from assumptions, anecdotes, vendor claims, and synthetic-data artifacts.
Failure modes: identify where the system can fail technically, operationally, legally, ethically, or socially.
Deployment readiness: connect metrics to decision thresholds, monitoring, escalation, and rollback.
Why This Module Matters#
In AINS6102: AI for Clinical Decision Support, this module contributes to the larger course arc by requiring students to turn a domain problem into an inspectable technical artifact. The standard is not “the notebook ran.” The standard is that another reviewer can understand the decision, reproduce the reasoning, and challenge the assumptions.
Method Pattern#
State the stakeholder decision in one sentence.
Identify the evidence source and why it is adequate or inadequate.
Produce a baseline result using the lab or an equivalent transparent method.
Compare one alternative design, threshold, policy, or model.
Document false positives, false negatives, unintended incentives, and operational constraints.
Recommend a next action: continue research, run a controlled pilot, redesign the system, or stop.
Failure Modes To Check#
Measurement mismatch: the metric optimizes something adjacent to, but not identical with, the real decision.
Context loss: important operational or human factors are absent from the data.
Automation bias: users may over-trust a score, classification, or recommendation.
Equity and access risk: affected groups may experience different error rates or burdens.
Governance gap: no one owns monitoring, escalation, or rollback after launch.
Study Questions#
What decision does the module artifact support?
What does the proxy lab evidence prove, and what does it not prove?
Which baseline or manual process should the AI-enabled approach be compared against?
Which stakeholder would object to the recommendation, and on what grounds?
What monitoring signal would tell you the system is failing after deployment?
Worked Example: From Evidence to a Decision#
Return to the professional situation for this module: You are advising a clinical informatics committee evaluating decision support before adding it to a clinician workflow. The immediate task is to decide what evidence would make a recommendation credible, what risks remain unresolved, and what should happen next. The module’s work product is: clinical decision support safety case with escalation, override, and monitoring requirements focused on treatment planning and personalization: Prototype a treatment option explanation.. The team should not begin by selecting the most sophisticated tool. First, rewrite the situation as a decision: what must be decided, by whom, using which evidence, and under which constraints? That sentence establishes the boundary of the analysis.
Next, create an inspectable baseline. For this module, a useful baseline should make Problem framing: define the decision, population, workflow, or system boundary before choosing a method. visible rather than hiding it inside an unsupported conclusion. Preserve the starting data or case facts, record the initial result, and identify the assumption most likely to change the recommendation. Then make one controlled comparison using Baseline discipline: compare the proposed AI-enabled approach with an existing process, simple rule, or manual review pattern.. Holding the other conditions fixed is what lets a reviewer interpret the difference.
Finally, connect the evidence to action. Use Evidence quality: separate measured results from assumptions, anecdotes, vendor claims, and synthetic-data artifacts. to explain why the observed result matters in the scenario, then state a limitation. The appropriate conclusion is conditional: recommend a next step only if the evidence clears a named threshold or review gate. This pattern—decision, baseline, controlled comparison, limitation, next gate—is the same structure expected in the assignment and rubric.
Comprehension Check#
Before continuing, be able to answer: What is the baseline? What single factor changes? Which evidence would reverse the recommendation? What does the exercise leave unknown?
Subject-Matter Lesson#
Treatment support operates within an established diagnosis and intended clinical role. Patient-specific evidence may include severity, comorbidities, renal or hepatic function, allergies, interactions, prior response, pregnancy, goals, access, burden, and affordability. These data can be stale, missing, or socially patterned. Personalization should not infer preferences or withhold options because access barriers are treated as biological suitability.
The system distinguishes eligibility, contraindication, relative tradeoff, evidence uncertainty, and patient preference. It presents alternatives including no change, states why each option is included or excluded, identifies missing information, and leaves orders to authorized clinicians. Shared decision making requires accessible explanation and patient values, not a recommendation with a decorative explanation.
The lab excludes an option for renal contraindication and ranks remaining eligible choices by evidence, preference fit, and burden. Change the patient preference and show which tradeoff changes without altering contraindications. Synthetic option scoring is not clinical advice; real implementation requires current guidelines, pharmacist and specialty review, interaction services, data verification, workflow testing, monitoring, and governance.